Endometrial ablation devices market accounted for a market value of US$ 985.8 Mn in 2017 and projected to grow at a CAGR of 5.3% during the forecast period from 2018 to 2026. Abnormal uterine bleeding is one of the most prevalent gynaecological diseases observed in last decade and if remained untreated may lead to low red blood cells count and anaemia. Endometrial ablation treatment is considered the most effective treatment for patients suffering from abnormal uterine bleeding. According to several research studies, the prevalence of menorrhagia in a range of 9% to 14% specifically in research studies that analysed menstrual blood loss by measuring it. However, a few studies based on subjective assessment suggested that the prevalence of menorrhagia is much higher than that in a range from 20% to 52%.

Radiofrequency endometrial ablation devices will maintain its dominance throughout the forecast period due to supportive reimbursement policies, high preference & support received from medical practitioners and cost-effective for patients from developing & underdeveloped countries. The increasing prevalence of gynecological disorders is also one of the key reasons responsible for the growth of the endometrial ablation devices market. According to the Department of Epidemiology and Preventive Medicine, a population-based survey carried out in the United States of women aged 18 to 50 years suggested that an annual prevalence rate of abdominal uterine bleeding is 53 per 1000 women.

"With rising prevalence of abnormal uterine bleeding and supportive reimbursement policies for endometrial ablation North America identified as the largest market"

North America dominated the overall endometrial devices due to key factors important for driving the market growth such as high prevalence of abnormal uterine bleeding, supportive reimbursement policies, high awareness related to latest endometrial ablation devices, and the increasing number of ambulatory surgery centers. The Asia Pacific is the fastest growing market due to factors such as the mounting prevalence of gynecological disorders due to lack of awareness & hygiene and a huge gap in healthcare services & unmet medical needs of patients from developing countries such as India & China.

The major players present in the market analyzed based on financial information, product portfolio, recent market updates, and key market strategies. This report also comprises attractive investment proposition analyzed with the help of exhaustive geographical research based on PESTEL analysis. Key players profiled in the report include Hologic Corporation, Boston Scientific Corporation, KARL STORZ GmbH & Co. KG, Minerva Surgical, Inc., Olympus Corporation, Smith & Nephew plc, The Cooper Companies, Inc., Ethicon, Inc., Medtronic plc, Richard Wolf GmbH, AngioDynamics Inc. among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Endometrial Ablation Devices market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Endometrial Ablation Devices market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Endometrial Ablation Devices market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Endometrial Ablation Devices market?
• Which is the largest regional market for Endometrial Ablation Devices market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Endometrial Ablation Devices market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Endometrial Ablation Devices market worldwide?